ADDvise Group’s nomination committee for the Annual General Meeting 2022

08-10-2021   Regulatory press release

In accordance with the resolution at the 2021 annual general meeting of ADDvise Group AB, the nomination committee for the annual general meeting 2022 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register, which is maintained by Euroclear Sweden as of 30 June 2021, and the chairman of the board of directors acting as rapporteur. The representative appointed by the largest shareholder by votes shall be appointed chairman of the nomination committee.

The nomination committee has now been appointed and consists of the following members:

  • Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership
  • Per Åhlgren, shareholder through indirect ownership
  • Magnus Vahlquist, shareholder through direct and indirect ownership
  • Staffan Torstensson, chairman of ADDvise Group AB

The nomination committee shall prepare proposals for the 2022 annual general meeting regarding the appointment of chairman of the meeting, chairman of the board of directors, and other directors of the board and remuneration to the directors of the board and to the auditor.

Shareholders, who wish to present proposals to the nomination committee for the 2022 annual general meeting can submit them by post no later than 31 January 2022 to: ADDvise Group AB, att: Nomination Committee, Grev Turegatan 30, SE-114 38 Stockholm.

The Annual General Meeting 2022 in ADDvise Group AB will be held on the 6 May 2022.

For further information, please contact:

Hanna Myhrman, General Counsel
+46 709 82 92 23

hanna.myhrman@addvisegroup.se



About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.    

Latest press releases

ADDvise receives allocation decision worth approximately EUR 5 million

Regulatory

ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Oulu University Hospital in Finland regarding a long-term partnership for delivery of x-ray equipment and services during a ten-years period, with a total value of EUR 5 million. First installations are expected to take place during the year 2023. In accordance with…

ADDvise acquires Southern Life Systems, Inc.

Regulatory

ADDvise Group AB has today entered into a share purchase agreement with the owners of Sothern Life Systems, Inc. (“SLS”) regarding the acquisition of all shares of SLS in accordance with the letter of intent communicated via a press release dated August 30, 2021. Closing of the acquisition takes place today. SLS’ revenue for the…

ADDvise Group appoints interim CFO

Regulatory

ADDvise Group AB appoints Bengt Miller as interim Chief Financial Officer (CFO) and temporary member of the management team. He succeeds the current CFO, Aaron Wong, and will assume the role on 29 November 2021 until the 28[th] of February 2022 when the newly appointed CFO, Sebastian Robson, as previously communicated, commences his employment. Bengt…

ADDvise receives order worth USD 530,000

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Masarat in Saudi Arabia, a company providing biosafety- and cleanroom services. The order is worth approximately USD 530,000 and involves design and construction of a cleanroom facility for the manufacturing of surgical sutures for Advanced Bio-Medical Industrial Co in Saudi Arabia. Delivery of…